Future Technologies Initiative

Helmsley’s Type 1 Diabetes Program has launched a Request for Proposals – the Future Technologies Initiative (FTI). The goal of the FTI is to incubate proof-of-concept, early-stage research and development in the following two tracks:

(1) Novel insulin and glucagon delivery technologies

(2) Novel sensing technologies

We are seeking projects that are high-risk, high-impact, and have long-term vision to significantly improve glucose control while reducing the burden of living with type 1 diabetes. We encourage bold, out-of-the-box thinking, novel approaches, and partnerships that incorporate technologies and expertise outside of the diabetes field.

Use the following resources to begin an application:

- Request for Proposals

- LOI  

- Required supplemental questionnaire

- Budget template (nonprofit organizations)

- Budget template (for-profit organizations)


  • Funding opportunity released – JANUARY 16, 2018
  • Letter of Inquiry (LOI) submission deadline – MARCH 16, 2018
  • Selected applicants proceed to full proposal – APRIL 2018
  • Full proposal submission deadline – JUNE 15, 2018
  • Anticipated commencement of selected programs – LATE SUMMER/FALL 2018

Questions? Please view our Frequently Asked Questions and direct any program-related questions about eligibility to t1dtechnology@helmsleytrust.org and online application questions to grants@helmsleytrust.org.